Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2318
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART) ; volume:10 ; number:1 ; day:19 ; month:5 ; year:2010 ; pages:1 ; date:8.2010
BMC geriatrics ; 10, Heft 1 (19.5.2010), 1, 8.2010
- Urheber
-
Bisicchia, F.
- Beteiligte Personen und Organisationen
-
Celesia, B M.
La Rosa, R.
Mavilla, S.
Gussio, M.
Mughini, M T.
Palermo, F.
Russo, R.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2318-10-S1-A87
- URN
-
urn:nbn:de:1111-2016021822488
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bisicchia, F.
- Celesia, B M.
- La Rosa, R.
- Mavilla, S.
- Gussio, M.
- Mughini, M T.
- Palermo, F.
- Russo, R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
HAART in HIV+ naive elderly patients: immuno-virological response and clinical outcome
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
Virological treatment outcome under HAART: does sex matter?
Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART
Tolerability of antiretroviral therapy (HAART) in elderly age
The prognosis of patients with dissociated virological and immunological responses to HAART
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Long-term virological outcome in children receiving first-line antiretroviral therapy
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART
Is HAART based on newest active antiretroviral drugs influenced by GSS?
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study
HAART in HIV+ naive elderly patients: immuno-virological response and clinical outcome
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
Virological treatment outcome under HAART: does sex matter?
Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART
Tolerability of antiretroviral therapy (HAART) in elderly age
The prognosis of patients with dissociated virological and immunological responses to HAART
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Long-term virological outcome in children receiving first-line antiretroviral therapy
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART
Is HAART based on newest active antiretroviral drugs influenced by GSS?
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study
HAART in HIV+ naive elderly patients: immuno-virological response and clinical outcome
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
Virological treatment outcome under HAART: does sex matter?
Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART
Tolerability of antiretroviral therapy (HAART) in elderly age
The prognosis of patients with dissociated virological and immunological responses to HAART
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Long-term virological outcome in children receiving first-line antiretroviral therapy
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART
Is HAART based on newest active antiretroviral drugs influenced by GSS?
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression